These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 10213801)
21. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. Marinelli L; Cosconati S; Steinbrecher T; Limongelli V; Bertamino A; Novellino E; Case DA ChemMedChem; 2007 Oct; 2(10):1498-510. PubMed ID: 17849398 [TBL] [Abstract][Full Text] [Related]
22. The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence. Nagy J Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):169-79. PubMed ID: 15180478 [TBL] [Abstract][Full Text] [Related]
23. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381 [TBL] [Abstract][Full Text] [Related]
24. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices. Mallon AP; Auberson YP; Stone TW Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338 [TBL] [Abstract][Full Text] [Related]
25. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. Coughenour LL; Cordon JJ J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267 [TBL] [Abstract][Full Text] [Related]
26. Developmental regulation of NMDA receptor 2B subunit mRNA and ifenprodil binding in the zebra finch anterior forebrain. Basham ME; Sohrabji F; Singh TD; Nordeen EJ; Nordeen KW J Neurobiol; 1999 May; 39(2):155-67. PubMed ID: 10235671 [TBL] [Abstract][Full Text] [Related]
27. Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus. Lozovaya NA; Grebenyuk SE; Tsintsadze TSh; Feng B; Monaghan DT; Krishtal OA J Physiol; 2004 Jul; 558(Pt 2):451-63. PubMed ID: 15146049 [TBL] [Abstract][Full Text] [Related]
32. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors. Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693 [TBL] [Abstract][Full Text] [Related]
33. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Feng B; Tse HW; Skifter DA; Morley R; Jane DE; Monaghan DT Br J Pharmacol; 2004 Feb; 141(3):508-16. PubMed ID: 14718249 [TBL] [Abstract][Full Text] [Related]
34. Excitatory amino acid receptors of the electrosensory system: the NR1/NR2B N-methyl-D-aspartate receptor. Harvey-Girard E; Dunn RJ J Neurophysiol; 2003 Feb; 89(2):822-32. PubMed ID: 12574460 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition. Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927 [TBL] [Abstract][Full Text] [Related]
36. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Wang CX; Shuaib A Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):143-51. PubMed ID: 15857299 [TBL] [Abstract][Full Text] [Related]
37. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses. Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856 [TBL] [Abstract][Full Text] [Related]
38. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Ma YY; Guo CY; Yu P; Lee DY; Han JS; Cui CL Exp Neurol; 2006 Aug; 200(2):343-55. PubMed ID: 16631172 [TBL] [Abstract][Full Text] [Related]
39. CP-101,606, a potent neuroprotectant selective for forebrain neurons. Menniti F; Chenard B; Collins M; Ducat M; Shalaby I; White F Eur J Pharmacol; 1997 Jul; 331(2-3):117-26. PubMed ID: 9274969 [TBL] [Abstract][Full Text] [Related]
40. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]